PUMILIO/FOXP1 Signaling Drives Expansion of Hematopoietic Stem/progenitor and Leukemia Cells
Overview
Authors
Affiliations
RNA-binding proteins (RBPs) have emerged as important regulators of invertebrate adult stem cells, but their activities remain poorly appreciated in mammals. Using a short hairpin RNA strategy, we demonstrate here that the 2 mammalian RBPs, PUMILIO (PUM)1 and PUM2, members of the PUF family of posttranscriptional regulators, are essential for hematopoietic stem/progenitor cell (HSPC) proliferation and survival in vitro and in vivo upon reconstitution assays. Moreover, we found that PUM1/2 sustain myeloid leukemic cell growth. Through a proteomic approach, we identified the FOXP1 transcription factor as a new target of PUM1/2. Contrary to its canonical repressive activity, PUM1/2 rather promote FOXP1 expression by a direct binding to 2 canonical PUM responsive elements present in the FOXP1-3' untranslated region (UTR). Expression of FOXP1 strongly correlates with PUM1 and PUM2 levels in primary HSPCs and myeloid leukemia cells. We demonstrate that FOXP1 by itself supports HSPC and leukemic cell growth, thus mimicking PUM activities. Mechanistically, FOXP1 represses the expression of the p21 and p27 cell cycle inhibitors. Enforced FOXP1 expression reverses shPUM antiproliferative and proapoptotic activities. Altogether, our results reveal a novel regulatory pathway, underscoring a previously unknown and interconnected key role of PUM1/2 and FOXP1 in regulating normal HSPC and leukemic cell growth.
Bangbo Z, Cheng Q, Zeru L, Tianyu L, Yutong Z, Weibin W Cell Mol Life Sci. 2025; 82(1):78.
PMID: 39961821 PMC: 11832970. DOI: 10.1007/s00018-025-05599-8.
Systematic analysis of the target recognition and repression by the Pumilio proteins.
Farberov S, Ulitsky I Nucleic Acids Res. 2024; 52(21):13402-13418.
PMID: 39470700 PMC: 11602169. DOI: 10.1093/nar/gkae929.
Diversity and structural-functional insights of alpha-solenoid proteins.
Arrias P, Osmanli Z, Peralta E, Chinestrad P, Monzon A, Tosatto S Protein Sci. 2024; 33(11):e5189.
PMID: 39465903 PMC: 11514114. DOI: 10.1002/pro.5189.
Zhuo Z, Wang J, Zhang Y, Meng G Int J Biol Sci. 2024; 20(11):4496-4512.
PMID: 39247833 PMC: 11380455. DOI: 10.7150/ijbs.98899.
Therapeutic efficacy of ECs Foxp1 targeting Hif1α-Hk2 glycolysis signal to restrict angiogenesis.
Pi J, Chang H, Chen X, Pan W, Zhang Q, Zhuang T Redox Biol. 2024; 75:103281.
PMID: 39083899 PMC: 11342203. DOI: 10.1016/j.redox.2024.103281.